Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elevance Health (ELV) has shared an announcement.
Elevance Health, Inc. is set to maintain optimistic communication with investors, affirming their net income guidance for the full year 2024 to exceed $34.05 per diluted share, despite some unfavorable items estimated at $3.15 per diluted share. Adjusted for these items, the net income is expected to surpass $37.20 per diluted share. This forecast is based on current projections and does not account for potential future adjustments. However, investors should be aware that these forward-looking statements are subject to various risks and uncertainties that could impact the company’s actual performance.
For a thorough assessment of ELV stock, go to TipRanks’ Stock Analysis page.